- Home
- ZTEK vs PRME Comparison
ZTEK vs PRME Comparison
Compare ZTEK & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTEK
- PRME
- Stock Information
- Founded
- ZTEK 2008
- PRME 2019
- Country
- ZTEK Canada
- PRME United States
- Employees
- ZTEK N/A
- PRME N/A
- Industry
- ZTEK Major Chemicals
- PRME Medicinal Chemicals and Botanical Products
- Sector
- ZTEK Industrials
- PRME Health Care
- Exchange
- ZTEK Nasdaq
- PRME Nasdaq
- Market Cap
- ZTEK 165.9M
- PRME 191.7M
- IPO Year
- ZTEK N/A
- PRME 2022
- Fundamental
- Price
- ZTEK $1.33
- PRME $2.07
- Analyst Decision
- ZTEK
- PRME Buy
- Analyst Count
- ZTEK 0
- PRME 6
- Target Price
- ZTEK N/A
- PRME $9.38
- AVG Volume (30 Days)
- ZTEK 29.1K
- PRME 2.3M
- Earning Date
- ZTEK 08-13-2025
- PRME 08-04-2025
- Dividend Yield
- ZTEK N/A
- PRME N/A
- EPS Growth
- ZTEK N/A
- PRME N/A
- EPS
- ZTEK N/A
- PRME N/A
- Revenue
- ZTEK $44,936.00
- PRME $3,846,000.00
- Revenue This Year
- ZTEK N/A
- PRME $104.12
- Revenue Next Year
- ZTEK N/A
- PRME $196.78
- P/E Ratio
- ZTEK N/A
- PRME N/A
- Revenue Growth
- ZTEK 92.38
- PRME 550.76
- 52 Week Low
- ZTEK $0.50
- PRME $1.11
- 52 Week High
- ZTEK $1.84
- PRME $6.75
- Technical
- Relative Strength Index (RSI)
- ZTEK 36.79
- PRME 71.75
- Support Level
- ZTEK $1.39
- PRME $1.56
- Resistance Level
- ZTEK $1.55
- PRME $1.85
- Average True Range (ATR)
- ZTEK 0.09
- PRME 0.19
- MACD
- ZTEK -0.02
- PRME 0.07
- Stochastic Oscillator
- ZTEK 2.04
- PRME 96.74
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.